Trulieve Cannabis (OTCMKTS:TCNNF – Free Report) had its price objective increased by Needham & Company LLC from $13.50 to $14.50 in a research note published on Friday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock.
Separately, Roth Mkm upped their price objective on Trulieve Cannabis from $16.00 to $19.00 and gave the stock a buy rating in a research report on Friday.
Check Out Our Latest Stock Report on Trulieve Cannabis
Trulieve Cannabis Stock Performance
OTCMKTS TCNNF opened at $11.90 on Friday. The business has a fifty day moving average price of $11.28 and a two-hundred day moving average price of $8.35. Trulieve Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $14.50.
About Trulieve Cannabis
(Get Free Report)
Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands.
Recommended Stories
Receive News & Ratings for Trulieve Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Trulieve Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.
Be the first to comment